Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 10, 2023 1:50pm
RE:Thanks Golden ...
Know it all Doctor Mr Mugsy, why do you not talk about that all LTAM is revolting and going left wing, and no one can afford any drugs. Further why Doctor knows it al Mugsy does not ask? Has any
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 10, 2023 12:04pm
Thanks Golden ...
Did listen to Biogen's CEO speak about the Alzheimer's drug. Far from a sure thing - lots of hurdles. He's positive about it but that's his job. Getting medicare coverage isn't a
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 07, 2023 8:09am
Do not believe Mugsy read facts for yourself
Listen to article Length5 minutes
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 07, 2023 7:58am
RE:Don't let Biogen's AD drug scare you ...
GUD spent over 200 milion to buy an old dug that is obsolte and to sell it to poor LATAM people while the rich in. lATAM will travel to the US and get the real biogen drug. As usual
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 06, 2023 10:33pm
Don't let Biogen's AD drug scare you ...
Just like I warned that Biogen's firs AD drug wasn't going to matter. I'm going to tell you that Biogen's second AD drug doesn't matter. You have to be able to understand what'
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 06, 2023 3:29pm
More bad news for GUD
https://www.cnbc.com/2023/01/06/alzheimers-disease-fda-decision-on-biogen-eisai-treatment-lecanemab.html?__source=newsletter%7Cbreakingnews
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 06, 2023 12:31pm
How Lula is investor friendly? Houch
https://www.ft.com/content/8608bab6-1ee4-4cfb-8a69-ee7caa4320d8
(5)
•••
Snowballgrowth
X
View Profile
View Bullboard History
Comment by
Snowballgrowth
on Jan 06, 2023 11:50am
RE:2023 Presentation ...
Take a look to branded generics (2023) ;)
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 04, 2023 12:51pm
RE:RE:2023 Presentation ...
I am going to guess that Synergy never pulled the trigger on going to the NASDAQ as the markets fell apart. Not sure how their sales are doing but paying back all of that loan likely fell apart.
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 04, 2023 10:40am
RE:RE:2023 Presentation ...
GUD ebb for 9 years and no flow in sight
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jan 04, 2023 8:32am
RE:2023 Presentation ...
I was looking for updates on Capital Structure on pg 15 that usually changes and an update on the synergy loan that matures in 2022. Looks like no changes made.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 04, 2023 6:41am
Mugsy + aliases and the Paladin lamp investment
My grandaughther when two year old kepT rubing the lamp ontop of the fireplace mantle hoping that the gene would pop out. Now at the age of five she concluded that it was a fun myth. Mr Mugsy allong
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 03, 2023 7:30pm
RE:2023 Presentation ...
312 MM in your dreams in colors
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 03, 2023 5:13pm
2023 Presentation ...
Anyone see anything new here ? Strong EBITDA and Cash Flow from Operations - same $312 MM in cash, securities and financial assets - same
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company